BOXED WARNING Increased mortality in elderly patients with dementia-related psychosis treated with antipsychotics; not approved for dementia-related psychosis.
FDA dosing
Population
Start
Target
Max
Psychotic disorders
Adult
2.5-10 mg/day divided q6-8h
<20 mg/day
40 mg/day
Psychotic disorders (maintenance)
Adult
1-5 mg/day, often single daily dose
1-5 mg/day
40 mg/day
Psychotic disorders
Geriatric
1-2.5 mg/day
per response
per response
Renal Undefined
Hepatic Contraindicated with liver damage
Instructions
Institute at low initial dose, increase as needed to clinical effect
When controlled, reduce gradually to maintenance
Oral dose is approximately 2-3x the parenteral dose